CA
MRK icon

Continuum Advisory’s Merck MRK Stock Holding History

Continuum Advisory’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Sell
9,850
-31
-0.3% -$3.63K 0.1% 178
2026
Q1 		$1.19M Buy
9,881
+807
+9% +$93.2K 0.11% 169
2025
Q4 		$955K Buy
9,074
+1,145
+14% +$107K 0.1% 193
2025
Q3 		$665K Buy
7,929
+127
+2% +$10.5K 0.07% 234
2025
Q2 		$618K Buy
7,802
+62
+0.8% +$4.93K 0.07% 232
2025
Q1 		$695K Sell
7,740
-341
-4% -$31.8K 0.09% 198
2024
Q4 		$804K Sell
8,081
-590
-7% -$60.8K 0.1% 179
2024
Q3 		$853K Buy
8,671
+299
+4% +$35.5K 0.11% 173
2024
Q2 		$1.04M Sell
8,372
-9
-0.1% -$1.16K 0.15% 147
2024
Q1 		$1.09M Sell
8,381
-2,816
-25% -$347K 0.16% 141
2023
Q4 		$1.22M Sell
11,197
-1,989
-15% -$206K 0.17% 149
2023
Q3 		$1.36M Sell
13,186
-1,625
-11% -$175K 0.22% 124
2023
Q2 		$1.71M Sell
14,811
-16,924
-53% -$1.92M 0.27% 95
2023
Q1 		$3.38M Sell
31,735
-90
-0.3% -$9.72K 0.57% 35
2022
Q4 		$3.53M Sell
31,825
-1,185
-4% -$121K 0.64% 28
2022
Q3 		$2.84M Buy
33,010
+3,086
+10% +$275K 0.5% 43
2022
Q2 		$2.73M Buy
29,924
+5,503
+23% +$488K 0.5% 45
2022
Q1 		$2.17M Buy
24,421
+16,158
+196% +$1.27M 0.41% 58
2021
Q4 		$633K Buy
8,263
+1,660
+25% +$132K 0.14% 155
2021
Q3 		$496K Buy
6,603
+541
+9% +$41.1K 0.13% 164
2021
Q2 		$471K Buy
+6,062
New +$451K 0.15% 155
2018
Q1 		– Sell
-4,914
Closed -$264K – 161
2017
Q4 		$264K Buy
4,914
+768
+19% +$42.6K 0.2% 126
2017
Q3 		$253K Buy
4,146
+430
+12% +$26.1K 0.22% 120
2017
Q2 		$227K Buy
+3,716
New +$226K 0.23% 126

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Continuum Advisory's MRK Position: Q2 2026 in Review

Continuum Advisory reduced its Merck (MRK) stake by 0.31% in Q2 2026, selling an estimated $3.63K and leaving 9,850 shares worth $1.27M. The position accounts for 0.1% of the portfolio, ranked #178.

Continuum Advisory first reported a position in MRK in Q2 2017 and has held it in 24 quarters since. The position peaked at $3.53M in Q4 2022. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Continuum Advisory held 9,850 shares of Merck worth $1.27M as of Q2 2026.
  • Continuum Advisory sold 31 Merck shares in Q2 2026, an estimated $3.63K.
  • Merck made up 0.1% of Continuum Advisory's portfolio in Q2 2026, its #178 holding.
  • Continuum Advisory first reported a position in Merck in Q2 2017 and has held it in 24 quarters since.
  • Continuum Advisory's Merck position peaked at $3.53M in Q4 2022.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.